Who invested in Human Longevity?
Human Longevity's investors include Draper Fisher Jurvetson (DFJ), Amino Capital, Illumina Ventures, Illumina and Bryan Johnson, and 1 more on record.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$110Mraised across 2 rounds since 2014, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $32M sold, first sale Mar 2023
From a historical funding record
From Human Longevity's own website: 2 on the team.
AdvisersRadiology Genomics
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Human Longevity's investors include Draper Fisher Jurvetson (DFJ), Amino Capital, Illumina Ventures, Illumina and Bryan Johnson, and 1 more on record.
Human Longevity has raised $110M across 2 rounds since 2014.
Human Longevity's most recent round was a Series B of $40M in Aug 2024.
Human Longevity's largest round on record is $70M (Series A), in Mar 2014.
Human Longevity's first round on record, in Mar 2014, was backed by Draper Fisher Jurvetson (DFJ), Illumina and Bryan Johnson and 1 others.
Human Longevity's latest named round is a Series B, in Aug 2024.
Human Longevity is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.